Per accedir als documents amb el text complet, si us plau, seguiu el següent enllaç: http://hdl.handle.net/2445/102886
Títol: | Serotypes and Clonal Diversity of Streptococcus pneumoniae Causing Invasive Disease in the Era of PCV13 in Catalonia, Spain |
---|---|
Autor/a: | Amo Moran, Eva del; Esteva, Cristina; Hernández Bou, Susanna; Galles, Carmen; Navarro, Marian; Sauca, Goretti; Díaz Conradi, Álvaro; Gassiot, Paula; Marti, Carmina; Larrosa, Nieves; Ciruela, Pilar; Jane, Mireia; Sá-Leao, Raquel; Muñoz-Almagro, Carmen; García García, Juan José; Catalan Study Group of Invasive Pneumococcal Disease [autoria conjunta] |
Altres autors: | Universitat de Barcelona |
Abstract: | The aim of this study was to study the serotypes and clonal diversity of pneumococci causing invasive pneumococcal disease in Catalonia, Spain, in the era of 13-valent pneumococcal conjugate vaccine (PCV13). In our region, this vaccine is only available in the private market and it is estimated a PCV13 vaccine coverage around 55% in children. A total of 1551 pneumococcal invasive isolates received between 2010 and 2013 in the Molecular Microbiology Department at Hospital Sant Joan de Déu, Barcelona, were included. Fifty-two serotypes and 249 clonal types defined by MLST were identified. The most common serotypes were serotype 1 (n = 182; 11.7%), 3 (n = 145; 9.3%), 19A (n = 137; 8.8%) and 7F (n = 122; 7.9%). Serotype 14 was the third most frequent serotype in children < 2 years (15 of 159 isolates). PCV7 serotypes maintained their proportion along the period of study, 16.6% in 2010 to 13.4% in 2013, whereas there was a significant proportional decrease in PCV13 serotypes, 65.3% in 2010 to 48.9% in 2013 (p<0.01). This decrease was mainly attributable to serotypes 19A and 7F. Serotype 12F achieved the third position in 2013 (n = 22, 6.4%). The most frequent clonal types found were ST306 (n = 154, 9.9%), ST191 (n = 111, 7.2%), ST989 (n = 85, 5.5%) and ST180 (n = 80, 5.2%). Despite their decrease, PCV13 serotypes continue to be a major cause of disease in Spain. These results emphasize the need for complete PCV13 vaccination. |
Matèries: | -Pneumococs -Vacunes -Pneumònia -Immunologia -Espanya -Catalunya -Streptococcus pneumonia -Vaccines -Pneumonia -Immunology -Spain -Catalonia |
Drets: | cc-by (c) del Amo, E. et al., 2016
http://creativecommons.org/licenses/by/3.0/es |
Tipus de document: | Article Article - Versió publicada |
Publicat per: | Public Library of Science (PLoS) |
Compartir: |